Intec Pharma Ltd.

110 articles about Intec Pharma Ltd.

• Intec Pharma Ltd. Receives An IRB Approval To Initiate Phase III Clinical Trial Of AP - CDLD For The Treatment Of Parkinson's Disease

  12/15/2015

• Intec Pharma Ltd. Enters Phase I Clinical Trial With Its Third Pipeline Product

  12/9/2015

• Intec Pharma Ltd. Reports Results For The Third Quarter of 2015

  11/9/2015

• Intec Pharma Ltd. Expands Intellectual Property With A New Patent For The Accordion Pill In Europe

  10/22/2015

• Intec Pharma Ltd. Announces Topline Results Of A Food Effect, Pharmacokinetic Study Of AP-CDLD 50/500mg For The Treatment Of Parkinson's Disease Symptoms

  10/14/2015

• Intec Pharma Ltd. Announces Partial Exercise Of Underwriters Option To Purchase Additional Ordinary Shares

  9/21/2015

• Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering

  8/10/2015

• Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering

  8/4/2015

• Intec Pharma Ltd. And IMPAX Laboratories, Inc. To Collaborate On CNS Drug Using Accordion Pill(TM) Gastric Retention Technology

  6/27/2006

• Intec Pharma Ltd. Collaborates With BioEnvelop Technologies And Tapemark - Gears Up Large-Scale Manufacturing Of SuperGeneric Drugs Using Accordion Pill(TM) Gastric Retention Technology

  6/15/2006